Home >> Professional Blog

MiMedx to Webcast Its Analyst Day on October 13, 2015

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced that it will be hosting and webcasting its Analyst Day on Tuesday, October 13, 2015, in New York.

Parker H. "Pete" Petit, Chairman and CEO; William C. Taylor, President and COO; Michael J. Senken, Chief Financial Officer; and numerous other members of MiMedx senior management will present and be on hand to participate in questions and answers.

The Analyst Day presentations will provide investors with a comprehensive overview of:

* Strategic Plans for 2016 and beyond;

* Third Quarter 2015 revenue results and full year 2015 forecast;

* Clinical and scientific study results of the Company's amniotic allografts and PURION® Process;

* Growth opportunities in Advanced Wound Care;

* Growth opportunities in the Surgical, Orthopedic and Sports Medicine area;

* Investment in the surgical sales channel and penetration of other key market segments;

* Update on the commercialization of the Company's proprietary patent-protected CollaFix™, MiMedx's second disruptive technology;

* Reimbursement progress with commercial health plans and government programs;

* Update on patent infringement lawsuits filed to protect the Company's intellectual property;

* Production efficiencies and expansion of placenta procurement network; and

* Presentation of certain surgical case studies by physicians.

In-person attendance at the presentations will be by invitation only. The webcast will be a listen-only simulcast of the presentations beginning at 10:00 AM EDT and concluding at approximately 2:30 PM EDT. The webcast will be available on-line at the Company's website www.mimedx.com. An on-line replay will be available approximately one hour following the conclusion of the live webcast. The replay will also be available on the Company's website at www.mimedx.com.